PT - JOURNAL ARTICLE AU - Ades, A E AU - Gordon, Fabiana AU - Scott, Karen AU - Collins, Jeannie AU - Thorne, Claire AU - Pembrey, Lucy AU - Chappell, Elizabeth AU - Mariné-Barjoan, Eugènia AU - Butler, Karina AU - Indolfi, Giuseppe AU - Gibb, Diana M AU - Judd, Ali TI - Overall vertical transmission of HCV, transmission net of clearance, and timing of transmission AID - 10.1101/2021.09.28.21264075 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.28.21264075 4099 - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264075.short 4100 - http://medrxiv.org/content/early/2021/09/29/2021.09.28.21264075.full AB - Background It is widely accepted that the risk of HCV vertical transmission (VT) is 5-6% in mono-infected women, and that 25-40% of HCV infection clears spontaneously within 5 years. However, VT and clearance rates have not been estimated from the same datasets, and there is a lack of information on VT rates “net” of clearance.Methods We re-analysed data on 1749 children in 3 prospective cohorts to obtain coherent estimates of overall VT rate and VT rates “net” of clearance at different ages. Clearance rates were used to impute the proportion of uninfected children who had been infected and then cleared before testing negative. The proportion of transmission early in utero, late in utero and at delivery was estimated from data on the proportion of RNA positives in samples tested within three days of birth, and differences between elective caesarean and non-elective caesarean deliveries.Findings Overall VT rates were 7.2% (95% credible interval 5.6-8.9) in mothers who were HIV negative and 12.1% (8.6-16.8) in HIV-co-infected women. The corresponding rates net of clearance at 5 years were 2.4% (1.1-4.1) and 4.1% (1.7-7.3). We estimated that 24.8% (12.1-40.8) of infections occur early in utero, 66.0% (42.5-83.3) later in utero, and 9.3% (0.5-30.6) during delivery.Conclusion Overall VT rates are about 24% higher than previously assumed, but the risk of infection persisting beyond age 5 years is about 38% lower. The results can inform design of trials of to prevent or treat pediatric HCV infection, and strategies to manage children exposed in utero.Key points Taking account of infections that would have cleared spontaneously before detection, the rate of HCV vertical transmission is 7.2% (95%CrI 5.6-8.9) in mono-infected women, but transmission “net” of clearance is 3.1% (1.8-4.4) at 3 years, and 2.4% (1.1-4.1) at 5.Competing Interest StatementClaire Thorne report payments from ViiV Healthcare for lectures, presentations, speakers bureaus, manuscript writing or educational eventsFunding StatementThis work was supported by the Medical Research Council [MR/R019746/1], through the Joint Global Health Trials scheme. Work at GOSICH was supported by the National Institute of Health Research Biomedical Research Centre, Great Ormond Street Hospital.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health Sciences Research Ethics Committee at the University of BristolAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data analysed for this paper was secondary. Individual patient data were requested from the studies listed in the manuscript and must be requested from the original research teams.